Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $7.9400 (16.25%) ($7.9400 - $7.9500) on Mon. Feb. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.35% (three month average) | RSI | 69 | Latest Price | $7.9400(16.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 4% a day on average for past five trading days. | Weekly Trend | CAPR advances 9.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) VCIT(78%) JNK(67%) SPY(63%) IVE(59%) XLK(57%) | Factors Impacting CAPR price | CAPR will decline at least -3.675% in a week (0% probabilities). VXX(-28%) USO(-7%) TBT(-24%) PEJ(-7%) XLU(7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.675% (StdDev 7.35%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $6.98(13.75%) | 10 Day Moving Average | $6.64(19.58%) | 20 Day Moving Average | $6.01(32.11%) | To recent high | 0% | To recent low | 51.2% | Market Cap | $156m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |